Land: Verenigd Koninkrijk
Taal: Engels
Bron: VMD (Veterinary Medicines Directorate)
Nandrolone
Intervet UK Ltd
QA14AB01
Nandrolone
Expired
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE V ETERINARY MEDICINAL PRODUCT FOLLOWED BY THE STRENGTH AND THE PHARMACEUTICAL FORM Laurabolin 50 mg/ml, solution for injection 2 NAME AND PROPORTION OF EACH ACTIVE SUBSTANCE, AND OF ANY EXCIPIENT, IF KNOWLEDGE OF THE EXCIPIENT IS NEEDED FOR SAFETY REASONS Each ml contain as the active substance: Nandrolone laurate 50 mg equivalent to nandrolone 15 mg Other substance: Benzyl alcohol 10.4% w/v For full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Solution for injection. Light yellow oily solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Nandrolone is a testosterone derivative which can be used in the supportive management of chronic renal failure. 4.3 CONTRA-INDICATIONS Laurabolin should not be used in pregnant animals. 4.4 SPECIAL WARNING FOR EACH TARGET SPECIES To be used with caution in known cases of hepatic impairment. 4.5 SPECIAL PRECAUTIONS FOR USE (i) Special precautions for use in animals None. (ii) Special precautions to be taken by the person administering the medicinal product to the animals Virilisation of the foetus may occur in pregnant women. Thus it is advisable that pregnant women avoid using this product. Avoid accidental self-injection of this product. Wash hands after use. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) Androgenic side effects may be seen in animals treated with Laurabolin, especially in entire female animals. The product may cause a strong urine odour in cats. 4.7 USE DURING PREGNANCY OR LACTATION Laurabolin is contra-indicated in pregnant animals 4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND O Lees het volledige document